This startup designs synthetic anti-infective polymers using an AI-driven platform. These polypeptides mimic natural antimicrobial peptides, offering a novel approach to combatting drug-resistant infectious diseases.
Funding
Funding not disclosed
Founders
Product
Problem
The rise of drug-resistant microorganisms has led to a critical need for new anti-infective solutions across therapeutics, medical devices, and biocides. Traditional antimicrobial development has slowed, while infections caused by resistant organisms result in over a million deaths annually and significant long-term health consequences. Existing solutions often lack effectiveness against biofilms and face increasing challenges with bacterial resistance.
Solution
VIKYNG-AI offers a technology platform that leverages artificial intelligence to design and generate synthetic anti-infective polypeptoids. These polymers mimic the structural features of natural antimicrobial peptides, providing a novel approach to combatting drug-resistant infections. The platform allows for precise control over the physicochemical properties of synthesized polymers, including composition, size, and charge, to tailor antimicrobial activity. By integrating a Quantitative Structure-Activity Relationship (QSAR) model into its AI, VIKYNG-AI accelerates the discovery and selection of lead molecules with enhanced efficacy and reduced side effects. The platform supports the development of active ingredients for therapeutics, medical devices (such as coatings for implantable catheters), and biocide solutions, addressing a wide range of applications in the fight against antimicrobial resistance.
Target Audience
The primary target audience includes pharmaceutical companies seeking new therapeutic leads, medical device manufacturers looking for anti-infective coatings, and companies developing advanced disinfection and biocide solutions.
Features
- AI-driven platform for designing and generating novel polypeptoid structures
- QSAR model to predict bioactivity and optimize molecule properties
- Polypeptoids with tunable composition, size, and charge for targeted antimicrobial activity
- Demonstrated antibacterial activity of polypeptoid coatings on silicone surfaces using plasma technology
- Broad-spectrum anti-microbial activity with rapid action (bacteria killed within minutes)
- Potential for development of anti-biofilm molecules for medical device applications
- Ability to engineer molecules with specific capabilities by modifying monomer nature and ratios
- Polypeptoids show reduced development of antibacterial resistance